AU2003261874A1 - Adrenocortical hormone secretion controller - Google Patents

Adrenocortical hormone secretion controller

Info

Publication number: AU2003261874A1
Authority: AU; Australia
Prior art keywords: hormone secretion; adrenocortical hormone; controller; secretion controller; adrenocortical
Prior art date: 2002-09-02
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2003261874A

Inventor

Shoji Fukusumi

Shuji Hinuma

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Takeda Pharmaceutical Co Ltd

Original Assignee

Takeda Chemical Industries Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-09-02

Filing date

2003-09-01

Publication date

2004-03-29

2003-09-01 Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd

2004-03-29 Publication of AU2003261874A1 publication Critical patent/AU2003261874A1/en

Status Abandoned legal-status Critical Current

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
- G01N2333/723—Steroid/thyroid hormone superfamily, e.g. GR, EcR, androgen receptor, oestrogen receptor

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Hematology (AREA)
Biomedical Technology (AREA)
Molecular Biology (AREA)
Diabetes (AREA)
Biochemistry (AREA)
Urology & Nephrology (AREA)
Immunology (AREA)
Food Science & Technology (AREA)
Pain & Pain Management (AREA)
Biotechnology (AREA)
Cell Biology (AREA)
Neurosurgery (AREA)
Microbiology (AREA)
Neurology (AREA)
Rheumatology (AREA)
Endocrinology (AREA)
Physics & Mathematics (AREA)
Analytical Chemistry (AREA)
Obesity (AREA)
General Physics & Mathematics (AREA)
Pathology (AREA)
Toxicology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Biophysics (AREA)

AU2003261874A 2002-09-02 2003-09-01 Adrenocortical hormone secretion controller Abandoned AU2003261874A1 (en)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
JP2002-256522		2002-09-02
JP2002256522		2002-09-02
JP2003055104		2003-03-03
JP2003-55104		2003-03-03
PCT/JP2003/011160 WO2004022086A1 (en)	2002-09-02	2003-09-01	Adrenocortical hormone secretion controller

Publications (1)

Publication Number	Publication Date
AU2003261874A1 true AU2003261874A1 (en)	2004-03-29

Family

ID=31980561

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2003261874A Abandoned AU2003261874A1 (en)	2002-09-02	2003-09-01	Adrenocortical hormone secretion controller

Country Status (2)

Country	Link
AU (1)	AU2003261874A1 (en)
WO (1)	WO2004022086A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP4760378B2 (en) *	2004-01-09	2011-08-31	大正製薬株式会社	Novel uses of ligands for GPR103-like receptor protein
WO2005065702A1 (en) *	2004-01-09	2005-07-21	Taisho Pharmaceutical Co., Ltd.	Novel use of ligand to gpr103-like receptor protein
WO2006039256A1 (en) *	2004-09-29	2006-04-13	Glaxo Group Limited	Use of gpr103 agonists for modulating feeding behaviour

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2002537757A (en) *	1998-08-24	2002-11-12	アルファジーン・インコーポレイテッド	Secreted proteins and polynucleotides encoding them
KR20010080882A (en) *	1998-10-13	2001-08-25	리처드 피. 버군 쥬니어	Non-Endogenous, Constitutively Activated Human G Protein-Coupled Receptors
JP2003534767A (en) *	1998-11-20	2003-11-25	アリーナ・フアーマシユーチカルズ・インコーポレーテツド	Human orphan G protein-coupled receptor
EP1189944A4 (en) *	1999-06-21	2002-09-11	Smithkline Beecham Corp	G-PROTEIN COUPLED RECEPTOR AXOR16
AU6727900A (en) *	1999-08-27	2001-03-26	Takeda Chemical Industries Ltd.	Novel g protein-coupled receptor protein and dna thereof
WO2001048189A1 (en) *	1999-12-28	2001-07-05	Helix Research Institute	Novel guanosine triphosphate-binding protein-coupled receptors, genes thereof and production and use of the same
US6927041B2 (en) *	2000-07-06	2005-08-09	Bayer Corporation	Human neuropeptide Y-like G protein-coupled receptor
US20030027252A1 (en) *	2000-11-22	2003-02-06	Tularik, Inc.	Novel receptors

2003
- 2003-09-01 AU AU2003261874A patent/AU2003261874A1/en not_active Abandoned
- 2003-09-01 WO PCT/JP2003/011160 patent/WO2004022086A1/en not_active Ceased

Also Published As

Publication number	Publication date
WO2004022086A1 (en)	2004-03-18

Publication	Publication Date	Title
AU2003251323A1 (en)	2004-01-23	Delivery devices
SI1567063T1 (en)	2008-10-31	Foot controller for microsurgical system
AU2003252811A1 (en)	2003-09-22	Accessory control interface
AU2003226983A1 (en)	2003-11-03	Extra-substrate control system
AU2002353303A1 (en)	2003-07-24	Controlling application devices simultaneously
AU2003254957A1 (en)	2004-03-29	Controller
AU2003296895A1 (en)	2004-05-04	Combination therapy for controlling appetites
AU2003268028A1 (en)	2004-02-16	System for controlling insects
AU2003302205A1 (en)	2004-06-18	Joystick controller
AU2003233357A1 (en)	2003-09-16	Dressing aid
AUPS160602A0 (en)	2002-05-16	Therapeutic method
AU2003277179A1 (en)	2004-04-19	Elevator control apparatus
AU2003257360A1 (en)	2004-04-30	Dressing aids
EP1393957A3 (en)	2004-04-28	Electrical load controlling device
AU2003303222A1 (en)	2004-07-14	Mutant proteins showing increased secretion
AU2003226420A1 (en)	2003-11-03	Suction controlled extraction device
AU2003280669A1 (en)	2004-06-23	Controller
AU2003272570A1 (en)	2004-04-08	Dressing for catheter assembly
AU2002349553A1 (en)	2004-05-04	Remote controller
AU2003261874A1 (en)	2004-03-29	Adrenocortical hormone secretion controller
EP1648438A4 (en)	2008-07-16	(-)-hydroxycitric acid for controlling inflammation
AU2003294631A1 (en)	2004-06-30	Device for implanting occlusion means
AU2003221040A1 (en)	2004-05-25	Device controller
AU2003282073A1 (en)	2004-05-25	Tight control device
AU2002359999A1 (en)	2003-09-02	Electronic controlling mailbox for multi-residences

Legal Events

Date	Code	Title	Description
2005-06-02	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase